OR WAIT null SECS
April 30, 2020
Catalent and Johnson & Johnson announce joint investment and tech transfer to prepare for rapid scale-up and segregated cGMP commercial manufacturing capacity.
April 29, 2020
NIH trial shows remdesivir accelerates recovery; Gilead study shows similar efficacy for 5- and 10-day dosing.
April 02, 2020
But are innovations sufficient to increase adoption? CMOs are demanding better continuous bioprocessing options.
March 30, 2020
Johnson & Johnson announces clinical trial plans for COVID-19 vaccine candidate, as well as plans to produce 1 billion vaccine doses.
March 05, 2020
Research from data and analytics company GlobalData shows that CAR-T cell therapy innovations across APAC will make the global market for these therapies more competitive.
March 02, 2020
Emergency action to protect patients and the drug supply may have long-term implications.
February 14, 2020
The company has said that all three of its operating sites in China started back up on Feb. 12 and that it is closely monitoring the outbreak.
February 10, 2020
New funding brings competitors, and a leading healthcare products distributor, into the standardization effort.
February 06, 2020
Can the pharmaceutical industry embrace the goals of Quality 4.0?
February 01, 2020
CDMOs and CMOs will continue to invest in biopharmaceutical services and facilities as the bio/pharmaceutical industry looks to biosimilars and personalized medicine.